Vivantes Klinikum Friedrichshain
- Address
- Landsberger Allee 49, 10249 Berlin, Germany
Digestive System Diseases and Colon Cancer Research
The clinical trial program at Vivantes Klinikum Friedrichshain includes work in digestive system diseases, with a strong focus on colon cancer. The studies are designed to assess treatment strategies for people with locally advanced disease, with the goal of improving outcomes before surgery and refining how care is planned around standard treatment.
- Comparing preoperative therapy with surgery-based treatment approaches for colon cancer
- Evaluating the effectiveness of treatment planning in advanced, non-metastatic disease
- Supporting better decisions for patients with digestive tract malignancies
These trials aim to help define whether earlier systemic treatment can improve the overall management of colorectal cancer while maintaining a clear focus on practical care decisions.
Hemic and Lymphatic Diseases and Hemophilia Research
Another area of research at this Berlin site centers on hemic and lymphatic diseases, especially hemophilia A and hemophilia B. The studies are focused on long-term follow-up after gene therapy, with attention to safety, durability of benefit, and how well treatment effects persist over time.
- Tracking long-term safety in participants previously treated for hemophilia
- Observing durability of transgene expression after gene therapy
- Assessing sustained effectiveness in severe bleeding disorders
Research here is helping to build a clearer picture of how advanced therapies may support people living with hemophilia A and hemophilia B, especially when long-term treatment response is the key question.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vivantes Klinikum Friedrichshain
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients with Hemophilia A or Hemophilia B: A Phase 3 Cohort Study | Pfizer Inc. | Phase III | Recruiting | Jul 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Calcium Folinate | 1 | Unknown | 2025-04-01 | 2025-04-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.